Voriconazole Dosing and Interactions

Voriconazole dosing is unusual among antifungals because two people on the same milligrams can end up with blood levels that differ several times over. Genetics, liver function, interacting drugs and formulation all pull on the result, which is why levels are measured rather than assumed. Here is what drives the difference.

Voriconazole, a prescription medication, is a potent triazole antifungal medicine widely used to treat serious fungal or yeast infections in individuals aged 2 and above. However, its complex pharmacokinetics and numerous drug interactions necessitate careful dosing and monitoring. Voriconazole dosing depends in part on the formulation: it comes as a 200 mg powder for injection, a 40 mg/mL oral suspension made from powder for reconstitution, and 50 mg and 200 mg oral tablets.

Voriconazole side effects should be immediately reported to your doctor, including but not limited to rash, fever, swollen glands, yellow skin/eyes, headache, irregular heartbeats, etc.

What is Voriconazole?

Voriconazole is a broad-spectrum antifungal agent belonging to the triazole class. It is particularly effective against Aspergillus species, Candida species (including fluconazole-resistant strains), and other filamentous fungi.

Active Ingredients

The active ingredient in voriconazole is voriconazole itself.

Voriconazole Mechanism of Action

Voriconazole inhibits fungal cytochrome P450 (CYP450) 14-α-demethylase, a crucial enzyme in ergosterol biosynthesis. Ergosterol is a vital component of fungal cell membranes. By disrupting its synthesis, voriconazole compromises cell membrane integrity, leading to fungal cell death.

Voriconazole Metabolism

Voriconazole is primarily metabolized by hepatic CYP450 enzymes, specifically CYP2C19, CYP2C9, and CYP3A4. CYP2C19 exhibits significant genetic polymorphism, leading to substantial interindividual variability in voriconazole pharmacokinetics. This polymorphism is a major factor in the observed differences in drug exposure among patients.

Published CPIC guidance concludes that there is sufficient evidence to use CYP2C19 genotype when selecting and dosing voriconazole in patients at risk of invasive fungal infection. Book an at-home PGx test requiring just a cheek (buccal) swab.

Voriconazole Dosing and Administration

• Loading Dose: 6 mg/kg IV every 12 hours for 2 doses.
• Maintenance Dose: 4 mg/kg IV every 12 hours or 200 mg orally every 12 hours (adjusted based on therapeutic drug monitoring).
• Oral vs. Intravenous: Voriconazole has high oral bioavailability (~96%), but food can reduce absorption. IV formulation is preferred in critically ill patients or those unable to tolerate oral medication.
• Renal Considerations: The IV formulation contains cyclodextrin, which may accumulate in renal impairment (CrCl < 50 mL/min). In such cases, switching to oral voriconazole is recommended.
• Therapeutic Drug Monitoring (TDM): Recommended trough levels: 1-5.5 mcg/mL to balance efficacy and toxicity.

Do not mix voriconazole liquid with any other medicine or liquid.

Voriconazole Indications

Voriconazole is indicated for the treatment of:

• Invasive aspergillosis
• Serious Candida infections (including esophageal candidiasis)
• Fusariosis
• Scedosporiosis
• Other serious fungal infections

Voriconazole Interactions

Voriconazole’s metabolism through CYP450 enzymes makes it susceptible to numerous drug interactions.

• CYP450 Inhibitors: Drugs that inhibit CYP450 enzymes (e.g., macrolide antibiotics, protease inhibitors) can increase voriconazole levels, leading to toxicity.
• CYP450 Inducers: Drugs that induce CYP450 enzymes (e.g., rifampin, phenytoin, carbamazepine) can decrease voriconazole levels, reducing its efficacy.
• Drugs Affected by Voriconazole: Voriconazole can increase the levels of immunosuppressants (tacrolimus, cyclosporine), statins, benzodiazepines, and warfarin (raising INR and bleeding risk).
• Contraindicated Drugs: Rifampin, rifabutin, carbamazepine, long-acting barbiturates, St. John’s wort, and sirolimus are contraindicated with voriconazole.

Voriconazole Side Effects

In case of serious reactions seek immediate help. Call 911 or get emergency medical help if you have:

• Allergic reaction: Hives, swelling (face/throat), trouble breathing.
• Severe skin reaction: Fever, sore throat, burning eyes, painful skin, or blistering rash.
• Serious drug reaction: Rash, fever, swollen glands, muscle pain, severe weakness, unusual bruising, or yellow skin/eyes.

If receiving IV voriconazole, tell your doctor if you feel:

• Dizzy, nauseous, light-headed, sweaty.
• Have a headache, chest tightness, back pain, or trouble breathing.

Major Side Effects – Call Your Doctor

• Heart problems: Fast, pounding heartbeat, fluttering in chest, dizziness, shortness of breath.
• Skin issues: Severe sunburn.
• Vision changes: Blurry vision, trouble seeing colors.
• Unusual bleeding: Easy bruising, purple/red spots on skin.
• Slow heart rate: Weak pulse, fainting, slow breathing.
• Adrenal issues:
• High hormones: Weight gain, swelling, acne, mood swings, missed periods.
• Low hormones: Stomach pain, fatigue, muscle/joint pain, craving salt.
• Kidney problems: Little or no urine, swelling in feet or ankles.
• Liver problems: Nausea, vomiting, flu-like symptoms, jaundice (yellow skin/eyes).
• Electrolyte imbalance: Dizziness, numbness, muscle cramps, irregular heartbeat.

Common Side Effects

Cold/flu-like symptoms: Fever, chills, stuffy nose, cough, sore throat.

Bleeding/bruising: Nosebleeds, coughing up blood.

Heart issues: High/low blood pressure, fast heartbeat.

Stomach issues: Nausea, vomiting, diarrhea, constipation, bloating.

Swelling: Hands, feet.

Headaches & dizziness.

Rash & skin reactions.

Vision changes & hallucinations.

Abnormal liver tests.

An at home PGx (pharmacogenomics) test by RPh LABS can give you insights into how you may respond to 240+ medications.

Key Warnings & Adverse Effects

The US voriconazole label does not carry a boxed warning, but it does list warnings and precautions that matter in practice:

• Visual Disturbances: Blurred vision, photophobia, and altered color perception.
• Hepatotoxicity: Elevated liver enzymes and rare cases of acute liver failure.
• QT Prolongation: Risk of torsades de pointes.
• Long-Term Toxicities: Fluorosis, periostitis, and increased risk of squamous cell carcinoma with prolonged use.

CYP2C19 Pharmacogenetics and Personalized Dosing

Genetic variations in CYP2C19 significantly affect voriconazole metabolism:

• Poor metabolizers (CYP2C19*2/*2): Higher drug levels, increased toxicity risk.
• Ultrarapid metabolizers (CYP2C19*17/*17): Lower drug levels, risk of treatment failure.
• Intermediate metabolizers (CYP2C19*1/*2): Require closer monitoring.

Personalized Dosing Strategies:

• TDM to maintain effective plasma concentrations (1-5.5 mcg/mL).
• Genetic testing to inform the choice of antifungal and the starting dose, decided with your prescriber.

Why voriconazole dosing is so unpredictable

Most antifungals behave roughly the same way in most people. Voriconazole does not. Its clearance depends heavily on liver enzymes whose activity varies from person to person, and the relationship between dose and blood concentration is not a straight line.

That non-linear behaviour is the practical problem. A modest increase in dose can produce a much larger jump in concentration, so voriconazole dosing changes are made in small steps with a level check afterwards rather than by doubling and hoping.

• Genetics, mainly CYP2C19 activity, which can shift exposure in either direction
• Liver function, since mild to moderate cirrhosis usually calls for a reduced maintenance dose
• Age, because children clear voriconazole faster than adults per kilogram
• Other medicines that induce or inhibit the same enzymes
• The formulation and whether it is taken with food
• Inflammation, as a severe infection itself can slow clearance

Put together, these factors mean voriconazole dosing is a starting estimate that gets corrected with measurements. Nobody, including your prescriber, can reliably predict your concentration from your weight alone.

Therapeutic drug monitoring: the measurement that guides the dose

Therapeutic drug monitoring means measuring the drug in your blood and adjusting the dose to hit a target range. It is standard practice for voriconazole and it is the reason a course usually involves repeat blood draws.

The sample is taken as a trough, just before the next dose is due, once concentrations have had time to level out over the first several days. Taking the sample too early in a course, or at the wrong point in the dosing interval, produces a number that cannot be acted on.

Therapeutic drug monitoring gets repeated after any change that could move the level: a dose adjustment, a switch between intravenous and oral, a new interacting medicine, a change in liver function, or a course that is not working as expected.

What to do on the day of the test

Ask when the draw should be relative to your dose, and do not take the dose early to fit the appointment. Tell the team the exact time of your last dose, whether you took it with food, and whether you have missed any. Without that context a voriconazole trough result can be misread in either direction.

CYP2C19 poor metabolizer status and voriconazole

Voriconazole is broken down mainly by CYP2C19, with CYP3A4 and CYP2C9 contributing. CYP2C19 carries common variants that change activity, so it is one of the best studied gene-drug pairs in infectious disease.

A CYP2C19 poor metabolizer has two non-functional copies and clears voriconazole slowly, which drives concentrations up and raises the chance of visual changes, liver enzyme rises and other dose-related harm. At the other end, people with two copies of the increased-function CYP2C19*17 allele clear it quickly and risk levels too low to treat a serious fungal infection.

The CPIC guideline for voriconazole and CYP2C19 goes further than most: for adults who are a CYP2C19 poor metabolizer, or who are ultrarapid metabolizers, it recommends choosing a different antifungal rather than trying to make voriconazole dosing work. Intermediate and normal metabolizers start at standard doses with monitoring.

The FDA also lists CYP2C19 with voriconazole in its table of pharmacogenetic associations. For background on the gene itself, MedlinePlus has a plain summary of CYP2C19.

CYP2C19 is on the RPh Labs 20-gene panel, and because your DNA does not change, knowing whether you are a CYP2C19 poor metabolizer is a one-time result that also applies to clopidogrel, several antidepressants and proton pump inhibitors.

Voriconazole trough results and what happens next

A voriconazole trough is usually aimed at the range described in the original article above, roughly 1 to 5.5 mcg/mL, because below that band treatment failure becomes more likely and above it toxicity does.

If a voriconazole trough comes back low, the team looks first for a reason before raising the dose: a missed dose, food taken with the tablet, vomiting, or a new enzyme inducer. Only then is voriconazole dosing stepped up, followed by another level.

A high voriconazole trough is handled the same way in reverse. Common culprits are a newly added inhibitor, worsening liver function, or a CYP2C19 poor metabolizer genotype that was never checked. Visual changes and confusion often appear around the same time and are worth reporting immediately.

None of these adjustments are yours to make. Never change the dose, skip doses to bring a level down, or stop voriconazole because a number looked high. Stopping an antifungal mid-course during a serious fungal infection is its own danger, and the decision belongs to the prescriber who ordered the level.

Voriconazole side effects and the ones that need urgent care

Many voriconazole side effects are dose-related, which is another reason level testing matters. Visual changes are the classic example: blurred vision, light sensitivity and altered colour perception that usually settle once the course ends.

Other common voriconazole side effects include nausea, headache, rash, marked sun sensitivity and rises in liver enzymes. Longer courses have been linked to skin changes, bone and joint pain from fluoride accumulation, and a higher risk of skin cancer, which is why sun protection is standard advice for anyone on extended therapy.

Some voriconazole side effects need same-day attention. Call your prescriber for yellowing of the eyes or skin, dark urine, persistent vomiting, a spreading rash, fainting, or a fast or irregular heartbeat, since voriconazole can prolong the QT interval.

Get emergency help for a blistering or peeling rash, mouth sores with fever, swelling of the face or throat, or trouble breathing. Call 911 or your local emergency number. If a dose has been taken twice by mistake or a child has swallowed the medicine, call Poison Control in the US at 1-800-222-1222 while you get help.

Interactions that force a change in voriconazole dosing

Voriconazole sits in the middle of the CYP3A system, so it is both affected by other drugs and a cause of problems for them. Interactions are the most common reason a stable course suddenly goes off target.

• Strong inducers such as rifampin, rifabutin, carbamazepine and long-acting barbiturates are contraindicated because they can drop levels to nothing.
• St. John’s wort has the same effect and is easy to miss on a medicine list.
• Phenytoin lowers voriconazole levels while voriconazole raises phenytoin levels, so both need monitoring if the combination is unavoidable.
• Tacrolimus, cyclosporine and sirolimus all rise sharply on voriconazole; sirolimus is contraindicated.
• Warfarin effect increases, so expect closer INR checks.
• Some statins, benzodiazepines and opioids accumulate and may need substituting or reducing.

Tell every prescriber and pharmacist that you are taking voriconazole, including for short courses. Our medication list shows which of these medicines have a gene-based report on our panel, and several of them run through CYP2C19 or CYP2C9 as well.

When an interacting drug cannot be avoided, the usual answer is more frequent therapeutic drug monitoring and a planned dose change rather than stopping either medicine. Building that plan in advance is far easier than reacting to a level that has already gone wrong.

Oral, intravenous and taking voriconazole with food

Voriconazole is well absorbed by mouth, which is unusual for an antifungal and means many people finish a course at home after starting in hospital. The switch is not just convenience; it also avoids the intravenous carrier.

The intravenous formulation is solubilised with a cyclodextrin that can accumulate when kidney function is reduced, so oral therapy is generally preferred once someone can swallow and absorb reliably.

Food reduces absorption of the oral forms, so tablets and suspension are usually taken at least an hour before or an hour after a meal. Taking a dose with a large meal can be enough on its own to explain a low voriconazole trough.

Do not mix the oral suspension with other liquids or medicines, and use the measuring device supplied. Small handling details change exposure more with this drug than with most, which is why voriconazole dosing instructions are worth rereading rather than remembering.

Using a CYP2C19 result alongside monitoring

Genotype and blood levels answer different questions. A CYP2C19 result predicts which direction your concentrations are likely to go before the first dose; therapeutic drug monitoring tells you where they actually landed. Serious infections benefit from both.

Knowing in advance that you are a CYP2C19 poor metabolizer can change the antifungal chosen rather than just the dose, which is the point of testing early. Knowing it later still helps, because it explains a pattern of high levels that might otherwise look unexplained.

The RPh Labs at-home cheek swab kit covers CYP2C19 with 19 other genes and reports against more than 240 medications. The kit ships within one business day, shipping is free both ways, and results come back 7 to 10 business days after the sample reaches our Dallas lab. A PharmD pharmacist reviews every report and a free consultation is included.

One honest limitation: a test ordered today will not usually arrive in time to guide an antifungal started this week for an acute infection. It is most useful before planned immunosuppression, for people with repeated fungal infections, or as part of a broader medication review. See how it works for timing details.

Conclusion

Voriconazole is a valuable antifungal agent, but its pharmacokinetics, drug interactions, and genetic variability require careful monitoring. Therapeutic drug monitoring and pharmacogenetic testing help optimize dosing, improve efficacy, and minimize toxicity. More about PGx testing and genomic medicine.

Disclaimer: This blog is for informational purposes. Always consult a healthcare professional for guidance on voriconazole therapy or before taking any medical action.

Voriconazole dosing FAQ

How long does it take to reach a steady voriconazole trough?

Without a loading dose it can take several days, which is why loading doses are used for serious infections. Levels are usually first checked after those early doses, once concentrations have stopped climbing. Your prescriber picks the day, and the result only means something if the sample was a true trough.

Does being a CYP2C19 poor metabolizer rule out voriconazole completely?

Not always, but guidelines lean toward a different antifungal for adults with that genotype rather than trying to dose around it. If voriconazole is still the best option for the organism involved, expect a lower dose and much closer level monitoring, decided by the treating team.

Will the vision changes go away?

In most reports the visual disturbance is temporary and settles after the course finishes or the dose comes down. It is still worth reporting promptly, because it often signals that a level is high. Avoid driving at night while your vision is affected and tell your prescriber how long it lasts.

Can I drink alcohol on voriconazole?

Alcohol is not listed as a direct interaction, but both alcohol and voriconazole stress the liver, and liver enzyme rises are among the more common voriconazole side effects. Ask your prescriber about your own situation, especially if you already have abnormal liver tests or take other liver-affecting medicines.

Is therapeutic drug monitoring needed if I already know my genotype?

Yes. Genotype narrows the starting estimate; it does not measure what is in your blood today. Interactions, liver function, absorption and the infection itself all move concentrations after the first dose, so therapeutic drug monitoring stays part of care either way.

What should I do if I miss a dose?

Ask your prescriber or pharmacist rather than guessing, and do not take two doses together to catch up. Write down what you missed and when, because a missed dose is one of the most common reasons a level comes back lower than expected and can otherwise trigger an unnecessary dose increase.